Trials / Completed
CompletedNCT02546258
Evaluation of the Performance of a Fungal Nail Treatment on the Visual Signs of Onychomycosis
A Prospective, Open Label, Non-comparative Clinical Investigation to Evaluate the Performance of a Fungal Nail Treatment on the Visual Signs of Onychomycosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Reckitt Benckiser Healthcare (UK) Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, open label, non-comparative clinical investigation to evaluate the performance of a Fungal Nail Treatment on the visual signs of onychomycosis. The Fungal Nail Treatment is a CE Marked Class I Medical Device and is commercially available as an over-the-counter product. The ability of the Fungal Nail Treatment to treat the visual signs of mild fungal toenail infections will be determined by a reduction in the surface area of the infection over time. This will be assessed through visual quantification of the infected area from baseline, as measured by image analysis, throughout the treatment period, where subjects will follow instructions for use on the product pack and self-treat for the duration of the investigation or until their condition has resolved. Both subject and podiatrist will assess the improvement of signs and symptoms of the target nail.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | A Fungal Nail Treatment | treats the signs of mild fungal nail infections |
Timeline
- Start date
- 2014-08-25
- Primary completion
- 2014-11-21
- Completion
- 2014-11-21
- First posted
- 2015-09-10
- Last updated
- 2017-04-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02546258. Inclusion in this directory is not an endorsement.